Use of certain biologics or disease modifying antirheumatic drugs may be associated with cancer risk
1. The use of rituximab, abatacept and Janus kinase inhibitors (JAKis) in individuals with rheumatoid arthritis (RA) was associated with ...
Tag: TNF inhibitor
Initiation of targeted disease-modifying antirheumatic drugs in patients with rheumatoid arthritis not associated with reduced risk of Alzheimer disease and related dementia
1. There were no differences in the risk of Alzheimer disease and related dementia in patients with rheumatoid arthritis treated ...
Tofacitinib increases cardiovascular and cancer risk in rheumatoid arthritis
1. Patients with rheumatoid arthritis (RA) treated with tofacitinib showed a higher risk of developing major adverse cardiovascular events and ...
Treatment of immune-mediated inflammatory diseases with tumor necrosis factor inhibitors is associated with lower COVID-19 hospitalization and death rates compared to other treatments
1. Immune-mediated inflammatory disease patients treated with tumor necrosis factor (TNF) inhibitor were associated with fewer hospitalizations or deaths due ...
#VisualAbstact: Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System Events
1. Tumor necrosis factor inhibitor exposure in patients with autoimmune disease, particularly rheumatoid arthritis, was associated with increased risk of ...
